Public COA audit

Tirzepatide

Audited September 5, 2026

Incomplete documentation

Missing panels or key metadata — not enough evidence to treat this as a full certificate.

Legitimacy
45
Confidence
85%
Panels
1/7

Scored poorly because the file is incomplete or not a full COA, limited panel coverage (1/7), 3 critical findings, and notable note: "Heavy metals only - incomplete testing scope". To improve: upload the full certificate (or the matching sibling purity/endotoxin report) and include identity, purity, and endotoxin at minimum.

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
TZ20250915
Issue date
2025-11-12

Original certificate

Embedded copy of the stored COA PDF or image. Download it for your records — PeptIQ’s audit is separate from the lab document itself.

Loading original certificate…

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

1 of 7 present · 1 passed · 0 failed · 0 reported · 6 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Not on this certificate file · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Purity

    Not on this certificate file · core

    Reported purity percentage for the analyte.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    All Class 1 metals below limits; trace amounts of Silver (0.20850 µg), Barium (0.48650 µg), Copper (0.46900 µg), Calcium (11.10000 µg), Potassium (85.000 µg), Sodium (585.000 µg), Zinc (1.1600 µg) detected

  • Microbial

    Not on this certificate file

    Bioburden / microbial limits testing.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Endotoxin

    Not on this certificate file · core

    LAL or chromogenic endotoxin assay.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Sterility

    Not on this certificate file

    Sterility testing where applicable.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

  • Residual solvent / water

    Not on this certificate file

    Residual solvents or water content limits.

    No evidence on this file. Vendors sometimes publish separate purity and endotoxin reports for the same lot — check the brand page before treating this as “never tested.”

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing on this file

Not on this certificate file. Lowers file thoroughness; a sibling endotoxin/purity report for the same lot may still exist. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • Heavy metals only - incomplete testing scope

    This COA contains ONLY heavy metals testing (EPA 208/245 methods). No identity confirmation (MS, NMR, FTIR), no purity/HPLC, no endotoxin, no microbial, no sterility, no residual solvents/water. This is a partial report and cannot verify the compound is actually Tirzepatide or assess its pharmaceutical quality.

  • No identity confirmation

    No mass spectrometry, NMR, FTIR, or other identity testing present. Cannot confirm the sample is Tirzepatide.

  • No purity testing

    No HPLC, UPLC, or other purity analysis present. Cannot assess peptide purity or impurity profile.

  • Missing critical pharmaceutical panels

    No endotoxin (LAL/BET), microbial limits, or sterility testing. These are typically required for injectable peptides.

  • Issue date valid

    Published 2025-11-12, which is before the authoritative current date of 2026-09-05.

  • Lab information present

    TrustPointe Analytics LLC with full address (1743 142nd Ave Suite 4, Dorr, MI 49323), phone (616-359-9023), verification URL (TrustPointeLIMS.com with key FZFFH0Q9CDAB), and dual signatures (Ashlee Lust, President; Joshua Lust, Managing Director).

  • Batch/lot number present

    Client SID: TZ20250915, Sample ID: SPL-2076-R01

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.